Name: UMIN ID:
Unique ID issued by UMIN | UMIN000018202 |
---|---|
Receipt number | R000021051 |
Scientific Title | A Randomized, Open-label Phase III Trial to Evaluate the Efficacy and Safety of Pertuzumab Retreatment in Previously Pertuzumab, Trastuzuamb and Chemotherapy Treated Her2-Positive Metastatic Locally Advanced and Metastatic Breast Cancer(Study of Perjeta re-treatment for clinical outcomes) |
Date of disclosure of the study information | 2015/07/06 |
Last modified on | 2021/07/15 15:43:30 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2015/07/06 00:51:58 | ||
2 | Update | 2016/02/17 13:30:18 | Interventions/Control_1 Interventions/Control_1 Interventions/Control_2 Interventions/Control_2 |
|
3 | Update | 2016/07/06 09:24:05 | Name of primary person or sponsor Organization |
|
4 | Update | 2017/04/05 19:04:36 | Interventions/Control_1 Interventions/Control_1 Interventions/Control_2 Interventions/Control_2 |
|
5 | Update | 2018/08/23 17:44:47 | Public title |
|
6 | Update | 2018/08/24 10:10:34 | UMIN ID1 |
|
7 | Update | 2019/09/05 15:50:43 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Organization Zip code Address Address Last name of contact person Last name of contact person Zip code Address Address Organization Organization Address Address Tel |
|
8 | Update | 2019/09/05 16:02:23 | Recruitment status Date of IRB Anticipated trial start date |
|
9 | Update | 2019/09/05 16:05:19 | Number of participants that the trial has enrolled |
|
10 | Update | 2020/01/29 18:39:19 | Organization Organization Division name Organization Organization Institute |
|
11 | Update | 2020/01/29 18:48:10 | Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
12 | Update | 2021/07/02 20:30:02 | Last name of contact person Last name of contact person Name of person sending information Name of person sending information |
|
13 | Update | 2021/07/15 15:43:30 | Homepage URL |